Phenotype of ribonuclease 1 deficiency in mice

  1. Ronald T. Raines2,6,7
  1. 1Graduate Program in Molecular and Cellular Pharmacology, University of Wisconsin–Madison, Madison, Wisconsin 53706, USA
  2. 2Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
  3. 3Graduate Program Molecular and Cellular and Molecular Biology, University of Wisconsin–Madison, Madison, Wisconsin 53706, USA
  4. 4Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
  5. 5Department of Medicine/Hematology–Oncology, University of Wisconsin–Madison, Madison, Wisconsin 53706, USA
  6. 6Department of Biochemistry, University of Wisconsin–Madison, Madison, Wisconsin 53706, USA
  7. 7Department of Chemistry, University of Wisconsin–Madison, Madison, Wisconsin 53706, USA
  1. Corresponding author: rtraines{at}mit.edu

Abstract

Biological roles for extracellular RNA (eRNA) have become apparent. For example, eRNA can induce contact activation in blood via activation of the plasma proteases factor XII (FXII) and factor XI (FXI). We sought to reveal the biological role of the secretory enzyme ribonuclease 1 (RNase 1) in an organismal context by generating and analyzing RNase 1 knockout (Rnase1–/–) mice. We found that these mice are viable, healthy, and fertile, though larger than Rnase1+/+ mice. Rnase1–/– plasma contains more RNA than does the plasma of Rnase1+/+ mice. Moreover, the plasma of Rnase1–/– mice clots more rapidly than does wild-type plasma. This phenotype appeared to be due to increased levels of the active form of FXII (FXIIa) in the plasma of Rnase1–/– mice compared to Rnase1+/+ mice, and is consistent with the known effects of eRNA on FXII activation. The apparent activity of FXI in the plasma of Rnase1–/– mice was 1000-fold higher when measured in an assay triggered by a low concentration of tissue factor than in assays based on recalcification, consistent with eRNA enhancing FXI activation by thrombin. These findings suggest that one of the physiological functions of RNase 1 is to degrade eRNA in blood plasma. Loss of this function facilitates FXII and FXI activation, which could have effects on inflammation and blood coagulation. We anticipate that Rnase1–/– mice will be a useful tool for evaluating other hypotheses about the functions of RNase 1 and of eRNA in vivo.

Keywords

  • Received January 19, 2019.
  • Accepted April 27, 2019.

This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents